Pancreatic Cancer Detected Successfully

Preliminary results on a small sample set have accurately detected pancreatic cancer from blood samples with 92% sensitivity (true positives) and 95% specificity (true negatives). This marks the second cancer, ovarian being the first, accurately detected using our proprietary nanosensor in a lab-bench apparatus at the University of Pennsylvania.

Watch a demonstration of our lab-bench apparatus below.